These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 13207535)

  • 1. Intravenous vasopressors in surgical shock.
    WELCH JW
    Am J Surg; 1954 Dec; 88(6):922-7. PubMed ID: 13207535
    [No Abstract]   [Full Text] [Related]  

  • 2. [Application of noradrenalin & neosynephrine in the treatment of shock].
    CIESIELSKI L; STEFANOWSKA J
    Pol Tyg Lek (Wars); 1958 Mar; 13(12):431-5. PubMed ID: 13553928
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardiovascular analeptics & their place in the treatment of states of shock].
    RICORDEAU G
    Concours Med; 1958 Sep; 80(37):3919-22. PubMed ID: 13585794
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of shock associated with myocardial infarction.
    GRIFFITH GC; WALLACE WB; COCHRAN B; NERLICH WE; FRASHER WE
    Circulation; 1954 Apr; 9(4):527-32. PubMed ID: 13150516
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutics for the state of shock by the new hypertensors (noradrenalin and neo-synephrine); study of 20 cases].
    GREDER G
    Praxis; 1956 Nov; 45(46):1061-8. PubMed ID: 13389156
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of pressor agents in shock in myocardial infarction.
    GARAI O; SMITH KS
    Br Med J; 1958 Feb; 1(5065):247-51. PubMed ID: 13499913
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of surgical shock with arterenol.
    FREMONT RE; LUGER NM; SURKS SN; KLEINMAN A
    AMA Arch Surg; 1954 Jan; 68(1):44-56. PubMed ID: 13103973
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal functional response to vasopressor agents in shock.
    MORRIS GC; MOYER JH; BEAZLEY HL
    Surg Forum; 1955; 5():798-803. PubMed ID: 13247136
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative value and indications of 2 vasopressors: effortil and noradrenaline].
    TRAUTMANN P; SCHNOEBELEN R
    Anesth Analg (Paris); 1959; 16():725-7. PubMed ID: 13839214
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacology of peripheral sympathomimetics & the conclusions drawn from it for the treatment of shock & collapse].
    SCHNEIDER KW
    Dtsch Med J; 1958 May; 9(5):236-9. PubMed ID: 13547916
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal hemodynamic response to vasopressor agents in the treatment of shock.
    MOYER JH; MORRIS G; BEAZLEY HL
    Circulation; 1955 Jul; 12(1):96-107. PubMed ID: 14390705
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effortil, a synephrin derivative, in therapy of surgical shock].
    DIETRICH KF; GYCHA FP
    Dtsch Med Wochenschr; 1951 Oct; 76(40):1243-6. PubMed ID: 14896751
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical studies on a vasopressor agent: metaraminol (aramine). II. Observations on its use in the management of shock.
    WEIL MH
    Am J Med Sci; 1955 Oct; 230(4):357-69. PubMed ID: 13258566
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical aspects of shock. I. The effects of vasopressor agents in shock.
    Moyer JH; Mills LC
    R I Med J; 1966 Jan; 49(1):28-36. PubMed ID: 5216149
    [No Abstract]   [Full Text] [Related]  

  • 15. The dilemma of vasopressors and vasodilators in the therapy of shock.
    Shoemaker WC; Brown RS
    Surg Gynecol Obstet; 1971 Jan; 132(1):51-7. PubMed ID: 5538813
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pressor amines and cardiogenic shock. An evalution with special reference to the use of noradrenaline].
    Hillestad L
    Tidsskr Nor Laegeforen; 1965 Nov; 85(21):1621-4. PubMed ID: 5882929
    [No Abstract]   [Full Text] [Related]  

  • 17. Vasopressor agents for severe hypotension and shock: with particular emphasis on renal hemodynamic responses.
    MOYER JH; MORRIS G
    Postgrad Med; 1954 Oct; 16(4):287-96. PubMed ID: 13204241
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of vasopressor agents in the treatment of shock.
    LANSING AM; STEVENSON JA; McLACHLIN AD
    J Trauma; 1962 Jul; 2():386-98. PubMed ID: 14462222
    [No Abstract]   [Full Text] [Related]  

  • 19. The treatment of myocardial infarction with shock; advantages and disadvantages of use of levophed.
    SEGAL JA
    Conn State Med J; 1955 Jan; 19(1):14-7. PubMed ID: 13219922
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of cardiac shock by metaraminol.
    BESTERMAN EM
    Br Med J; 1959 Apr; 1(5129):1081-3. PubMed ID: 13638636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.